Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

10/16/2026
Impact: 75
Healthcare

Leerink Partners analyst David Risinger has maintained an 'Outperform' rating on First Tracks (NASDAQ: TRAX) and raised the price target from $70 to $90. This adjustment reflects a positive outlook for the company's performance in the market.

AI summary, not financial advice

Share: